A members network for financial professionals and private investors. We keep our eyes focused on Nordic Tech and Life Science based companies with global reach.
Stockholm, Sweden
Joined June 2010
- Tweets22.6K
- Following254
- Followers14.5K
- Likes766
Björn Borg trades below Redeye's Fair Value estimate of SEK 73.6 per share and has Market Edge scores of 4 for Value (Attractively Priced) and 3 for Momentum (Neutral). We spoke with our analyst about Björn Borg's business model and main sales channels, the competitive advantage in sports apparel, and other key topics.
This is a premium article, included in our paid plans from SEK 99/month.
$BORG
redeye.se/research/1187906/b…
Redeye provides a short comment on the recent press release announcing that the CADScor System has received regulatory approval in the Kingdom of Saudi Arabia.
$ACARIX
redeye.se/research/1187915/a…
Redeye updates its estimates ahead of Hacksaw’s Q3-results (due 3 November) where we align our forecasts to the preliminary results announced on October 12.
$HACK
redeye.se/research/1187864/h…
Redeye har inervjuat Anders Olin om hans tredje turnaround, varför problemet sitter i försäljningen och inte i tekniken, vad två konkursade konkurrenter betyder för Maven och vad som krävs för att nå tillbaka till lönsamhet.
$MAVEN
redeye.se/research/1187717/m…
Redeye comments on BioInvent’s ESMO 2026 abstract for BI-1808 plus pembrolizumab in platinum-resistant ovarian cancer, published over the weekend. No new data was published.
$BINV
redeye.se/research/1187790/b…
Redeye comments on Truecaller’s preliminary Q3 figures.
$TRUE
redeye.se/research/1187772/t…
Guldbrevs management will present the company’s latest quarterly report tomorrow, followed by an interactive discussion with Redeye analyst Henrik Alveskog.
📅 When: October 20, 2026, 10:00 CET
Ask your questions and watch the broadcast here: redeye.se/events/1172875/liv…
$GULD
Redeye provides an update following Plejd’s Q3 report.
$PLEJD
redeye.se/research/1187482/p…
Redeye provides an update following Maven Wireless’ Q3 report.
$MAVEN
redeye.se/research/1187747/m…
Redeye strengthens its positive view of q.beyond following solid Q3 new sales figures, driven mainly by momentum in the healthcare segment, an early encouraging sign for the recent GITG acquisition. We keep our forecasts for now but expect a positive bias in the upcoming estimate revisions for 2027 and beyond following the full Q3 report.
$QBY
redeye.se/research/1187736/q…
Redeye updates on Invisio ahead of Q3-results (due 30 October) where we expect strong YoY growth against a soft comparison quarter. Orders remain in focus and we expect a solid order intake that supports a positive outlook for Q4
$IVSO
redeye.se/research/1187614/i…
Redeye provides an update following Carasent’s Q3 report.
$CARA
redeye.se/research/1187135/c…
Redeye keeps its positive view and forecasts for Avensia following Q3 sales figures. The sales beat our forecast slightly driven by strong growth in IM.
$AVEN
redeye.se/research/1187572/a…
Redeye comments on I-Tech signing a license agreement with Titanium Technology to develop and commercialise a non-biocidal antifouling technology for aquaculture.
$ITECH
redeye.se/research/1187566/i…
AAC Clyde Space trades below Redeye's Fair Value estimate of SEK 150 per share and has Market Edge scores of 4 for Value (Attractively Priced) and 1 for Momentum (Very Weak). We spoke with our analyst about which KPIs investors should follow most closely over the coming quarters, the main share price catalysts over the next 12 months, and other key topics.
This is a premium article, included in our paid plans from SEK 99/month.
$AAC
redeye.se/research/1187263/a…
Redeye comments on KDventures’ portfolio company Modus pausing enrolment in part 2 of its phase IIa study of sevuparin in CKD with anaemia after a serious adverse event in one patient, with the proof-of-concept readout moving to Q1 2027. Redeye sees a limited direct valuation effect, as Modus is a small part of KDventures’ NAV.
$KDV
redeye.se/research/1187521/k…
Redeye comments on Hacksaw’s announcement of its entry into prediction markets, where it has launched a B2B offer which expands its platform beyond online casino games.
$HACK
redeye.se/research/1187517/h…
Redeye comments on Siljansvik’s subsidiary Dala Vind continuing to consolidate ownership in its existing wind portfolio through a SEK56.5m acquisition.
$SIVI
redeye.se/research/1187496/s…
